Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-15

Clinical Trial Update: The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on Mitizodone Phosphate Tablets for Major Depressive Disorder spanning Phase 2 and Phase 3, with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitizodone Phosphate Tablets (Mitizodone Phosphate)

Snippet

Sponsor: Sunshine Lake Pharma Co., Ltd. | Conditions: Depressive Disorder, Major | Phase 2, Phase 3 | Status: UNKNOWN